Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a4783407e23a20dbe43d383a5d0fcb5 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
filingDate |
2016-11-25^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_028c61228a9bde904e40a94f6285c837 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfc056e18ff8bc780de6d84f7b6b8b32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b79b4de61f5cda603ad7b03f4924d528 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_158593f71452bb11a6d91fe555d02656 |
publicationDate |
2017-03-02^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2017032908-A1 |
titleOfInvention |
Pharmaceutical composition comprising amorphous posaconazole |
abstract |
The present invention relates to a pharmaceutical composition comprising a solid dispersion of posaconazole and at least two different enteric polymers, wherein the solid dispersion is obtained by applying the process of wet granulation. The invention further relates to the use of said pharmaceutical composition as medicament in the treatment of invasive fungal infections. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11708463-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4091604-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10702520-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022034232-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023012378-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3342399-A1 |
priorityDate |
2016-07-08^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |